Page last updated: 2024-08-24

epigallocatechin gallate and dinoprostone

epigallocatechin gallate has been researched along with dinoprostone in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's15 (60.00)29.6817
2010's10 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allen, JG; Babij, P; Fotsch, C1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Choi, YJ; Kwon, TK; Park, JW; Suh, SI1
Ahmed, S; Goldberg, VM; Haqqi, TM; Hasnain, A; Lalonde, M; Rahman, A1
Imamura, M; Itami, A; Kaganoi, J; Kawabe, A; Komoto, I; Li, ZG; Maeda, M; Sato, F; Shimada, Y1
Hagihara, K; Koshimizu, K; Murakami, A; Ohigashi, H; Takahashi, D1
Lee, IS; Lee, SJ; Mar, W1
Cui, Y; Kim, DS; Kim, SK; Kwon, SB; Park, KC; Park, SH; Yoon, JA1
Ahn, BH; Joe, EH; Kim, SY; Lee, YH; Min, DS; Min, KJ1
Adhami, VM; Gupta, S; Hussain, T; Mukhtar, H1
Drewe, J; Porath, D; Riegger, C; Schwager, J1
Bose, M; Carothers, AM; Hong, J; Hou, Z; Ju, J; Liao, J; Lin, Y; Liu, YY; Ma, J; Pan, Z; Shih, WJ; Yang, CS; Yang, GY; Zhou, JN1
Deguchi, A; Joe, AK; Mckoy, JF; Moriwaki, H; Shimizu, M; Weinstein, IB1
Albini, A; Bagnato, A; Decandia, S; Di Castro, V; Elia, G; Natali, PG; Rosanò, L; Spinella, F1
An, NH; Hong, SH; Jeong, HJ; Kim, HM; Kim, SJ; Lee, HJ; Lee, KM; Myung, NY; Park, SK; Um, JY; Yang, WM1
Bauer, J; Hoffmann, M; Koeberle, A; Northoff, H; Verhoff, M; Werz, O1
Ha, J; Hwang, JT; Kwon, DY; Lee, YK; Park, IJ; Park, OJ1
Au, AY; Frondoza, CG; Grzanna, MW; Heinecke, LF; Mochal, CA; Rashmir-Raven, A1
Meydani, M; Meydani, SN; Pae, M; Ren, Z; Shang, F; Smith, D; Wu, D1
Katiyar, SK; Singh, T1
Ferrario, A; Gomer, CJ; Luna, M; Rucker, N; Wong, S1
Chang, JZ; Chen, HM; Deng, YT; Kuo, MY; Yang, WH1
Chang, Y; He, YF; Hu, SS; Jin, J; Wang, D; Wei, W; Wu, YJ1
Guan, F; Ju, J; Li, G; Liu, AB; Sun, Y; Yang, CS; Yang, Z1
Jin, J; Sun, H; Wang, M; Yang, H; Zhu, S1

Reviews

1 review(s) available for epigallocatechin gallate and dinoprostone

ArticleYear
Emerging targets in osteoporosis disease modification.
    Journal of medicinal chemistry, 2010, Jun-10, Volume: 53, Issue:11

    Topics: Animals; Biomarkers; Bone Density; Bone Resorption; Humans; Osteoporosis

2010

Other Studies

24 other study(ies) available for epigallocatechin gallate and dinoprostone

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cells.
    Biochemical and biophysical research communications, 2001, Aug-31, Volume: 286, Issue:4

    Topics: Animals; Catechin; Cell Line; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Flavonoids; Isoenzymes; Macrophages; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Protein Tyrosine Phosphatases; RNA, Messenger; Signal Transduction; Up-Regulation; Vanadates

2001
Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes.
    Free radical biology & medicine, 2002, Oct-15, Volume: 33, Issue:8

    Topics: Antioxidants; Catechin; Cells, Cultured; Chondrocytes; Cyclooxygenase 2; Depression, Chemical; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Interleukin-1; Isoenzymes; L-Lactate Dehydrogenase; Membrane Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Osteoarthritis; Prostaglandin-Endoperoxide Synthases; Reactive Oxygen Species; Tea

2002
Inhibitory effects of epigallocatechin-3-gallate on N-nitrosomethylbenzylamine-induced esophageal tumorigenesis in F344 rats.
    International journal of oncology, 2002, Volume: 21, Issue:6

    Topics: Animals; Anticarcinogenic Agents; Catechin; Cyclin D1; Cyclooxygenase 1; Cyclooxygenase 2; Dimethylnitrosamine; Dinoprostone; Disease Models, Animal; DNA Primers; Enzyme-Linked Immunosorbent Assay; Esophageal Neoplasms; Esophagus; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Urokinase-Type Plasminogen Activator

2002
Combinatorial effects of nonsteroidal anti-inflammatory drugs and food constituents on production of prostaglandin E2 and tumor necrosis factor-alpha in RAW264.7 murine macrophages.
    Bioscience, biotechnology, and biochemistry, 2003, Volume: 67, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Catechin; Cell Line; Cyclooxygenase Inhibitors; Dinoprostone; Drug Synergism; Food Analysis; Food-Drug Interactions; Genistein; Indicators and Reagents; Indomethacin; Interferon-gamma; Isothiocyanates; Lipopolysaccharides; Macrophages; Mice; Protein Biosynthesis; Spectrophotometry, Infrared; Sulfonamides; Tumor Necrosis Factor-alpha

2003
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose in murine macrophage cells.
    Archives of pharmacal research, 2003, Volume: 26, Issue:10

    Topics: Acetophenones; Animals; Catechin; Cell Line; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Gallic Acid; Humans; Hydrolyzable Tannins; Isoenzymes; Leukemia, Erythroblastic, Acute; Lipopolysaccharides; Macrophages; Medicine, Chinese Traditional; Membrane Proteins; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Paeonia; Plant Extracts; Plant Roots; Prostaglandin-Endoperoxide Synthases; Pyrogallol; Structure-Activity Relationship; Tannins

2003
Involvement of ERK AND p38 MAP kinase in AAPH-induced COX-2 expression in HaCaT cells.
    Chemistry and physics of lipids, 2004, Volume: 129, Issue:1

    Topics: Amidines; Catechin; Chromans; Cyclooxygenase 2; Dinoprostone; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Free Radical Scavengers; Humans; Imidazoles; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Keratinocytes; MAP Kinase Kinase 4; Membrane Proteins; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Prostaglandin-Endoperoxide Synthases; Pyridines

2004
Phospholipase D isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells.
    The Journal of biological chemistry, 2004, Sep-10, Volume: 279, Issue:37

    Topics: 1-Butanol; Animals; Astrocytes; Astrocytoma; Blotting, Western; Carbazoles; Catechin; Cell Line, Tumor; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Indoles; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphatidic Acids; Phospholipase D; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Protein Isoforms; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection

2004
Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells.
    International journal of cancer, 2005, Feb-10, Volume: 113, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acid; Catechin; Cell Division; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Humans; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tea; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator

2005
Epigallocatechin-3-gallate impairs chemokine production in human colon epithelial cell lines.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 315, Issue:3

    Topics: Antioxidants; Catechin; Cell Line, Tumor; Cell Survival; Chemokines; Colon; Colonic Neoplasms; Dinoprostone; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; HT29 Cells; Humans; Interleukin-8; Kinetics; Macrophage Inflammatory Proteins; Reverse Transcriptase Polymerase Chain Reaction; Tumor Necrosis Factor-alpha; Up-Regulation

2005
Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea.
    Cancer research, 2005, Nov-15, Volume: 65, Issue:22

    Topics: Animals; Anticarcinogenic Agents; beta Catenin; Cadherins; Caffeine; Catechin; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Female; Genes, APC; HT29 Cells; Humans; Intestinal Neoplasms; Intestine, Small; Leukotriene B4; Male; Mice; Mice, Inbred C57BL; Phospholipases A; Phosphorylation; Proto-Oncogene Proteins c-akt

2005
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells.
    Journal of experimental therapeutics & oncology, 2005, Volume: 5, Issue:1

    Topics: bcl-X Protein; Biotransformation; Blotting, Western; Catechin; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; DNA Fragmentation; Enzyme Induction; ErbB Receptors; Genes, erbB-2; Genes, Reporter; Humans; Immunoprecipitation; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Transcription Factor AP-1

2005
Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
    Experimental biology and medicine (Maywood, N.J.), 2006, Volume: 231, Issue:6

    Topics: Antineoplastic Agents; Catechin; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dinoprostone; Endothelin A Receptor Antagonists; Endothelin-1; Female; Humans; Ovarian Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Tea

2006
Epigallocatechin-3-gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells.
    The Journal of nutritional biochemistry, 2007, Volume: 18, Issue:9

    Topics: Amyloid beta-Peptides; Anti-Inflammatory Agents; Astrocytoma; Catechin; Cyclooxygenase 2; Dinoprostone; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; JNK Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2007
Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E(2) synthase-1.
    Biochemical and biophysical research communications, 2009, Oct-16, Volume: 388, Issue:2

    Topics: Anticarcinogenic Agents; Camellia sinensis; Catechin; Dinoprostone; Enzyme Inhibitors; Humans; Intramolecular Oxidoreductases; Microsomes; Prostaglandin H2; Prostaglandin-E Synthases

2009
Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2.
    Annals of the New York Academy of Sciences, 2009, Volume: 1171

    Topics: Acetylcysteine; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Apoptosis; Blotting, Western; Catechin; Cell Proliferation; Colonic Neoplasms; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Activation; Free Radical Scavengers; HT29 Cells; Humans; Hydrogen Peroxide; Oxidants; Poly(ADP-ribose) Polymerases; Reactive Oxygen Species; Ribonucleotides; Signal Transduction; Tea; Tumor Suppressor Protein p53

2009
Inhibition of cyclooxygenase-2 expression and prostaglandin E2 production in chondrocytes by avocado soybean unsaponifiables and epigallocatechin gallate.
    Osteoarthritis and cartilage, 2010, Volume: 18, Issue:2

    Topics: Aggrecans; Animals; Antioxidants; Cartilage, Articular; Catechin; Chondrocytes; Collagen Type II; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Gene Expression; Glycine max; Horses; Interleukin-1beta; NF-kappa B; Persea; Phenotype; Plant Extracts; Polymerase Chain Reaction; RNA; Tumor Necrosis Factor-alpha

2010
Dietary supplementation with high dose of epigallocatechin-3-gallate promotes inflammatory response in mice.
    The Journal of nutritional biochemistry, 2012, Volume: 23, Issue:6

    Topics: Animals; Biomarkers; Catechin; Dietary Supplements; Dinoprostone; Inflammation; Interleukin-1beta; Interleukin-6; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Natural Killer T-Cells; Plant Extracts; Spleen; Tea; Tumor Necrosis Factor-alpha

2012
Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE2 receptors and epithelial-to-mesenchymal transition.
    PloS one, 2011, Volume: 6, Issue:10

    Topics: Catechin; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Humans; Melanoma; Neoplasm Invasiveness; NF-kappa B; Pyrazoles; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides; Tea; Tetradecanoylphorbol Acetate; Transcription Factor RelA

2011
Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
    Lasers in surgery and medicine, 2011, Volume: 43, Issue:7

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Catechin; Cell Line, Tumor; Dihematoporphyrin Ether; Dinoprostone; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Inflammation; Mammary Neoplasms, Experimental; Matrix Metalloproteinases, Secreted; Mice; Mice, Inbred C3H; Photochemotherapy; Photosensitizing Agents; Unfolded Protein Response; Vascular Endothelial Growth Factors

2011
EGCG blocks TGFβ1-induced CCN2 by suppressing JNK and p38 in buccal fibroblasts.
    Clinical oral investigations, 2013, Volume: 17, Issue:2

    Topics: Anthracenes; Benzamides; Catechin; Cell Line; Cells, Cultured; Connective Tissue Growth Factor; Dinoprostone; Dioxoles; Dose-Response Relationship, Drug; Fibroblasts; Flavonoids; Humans; Imidazoles; Lung; MAP Kinase Kinase 4; Mouth Mucosa; Oral Submucous Fibrosis; p38 Mitogen-Activated Protein Kinases; Protease Inhibitors; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta1

2013
Prostanoid EP1 receptor as the target of (-)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro.
    Acta pharmacologica Sinica, 2012, Volume: 33, Issue:5

    Topics: Alprostadil; Antineoplastic Agents, Phytogenic; Blotting, Western; Bridged Bicyclo Compounds; Caproates; Carcinoma, Hepatocellular; Catechin; Cell Movement; Cell Proliferation; Cell Survival; Dinoprostone; Dose-Response Relationship, Drug; GTP-Binding Protein alpha Subunits, Gq-G11; Hep G2 Cells; Humans; Immunoassay; Liver Neoplasms; Neoplasm Invasiveness; Receptors, Prostaglandin E, EP1 Subtype; Time Factors

2012
Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation.
    Nutrition and cancer, 2012, Volume: 64, Issue:6

    Topics: Animals; Atorvastatin; Azoxymethane; Catechin; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Gastrointestinal Hemorrhage; Heptanoic Acids; Leukotriene B4; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Pyrroles; Rectum; Weight Loss

2012
Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinoma.
    Pharmacology, 2019, Volume: 104, Issue:5-6

    Topics: Alprostadil; Apoptosis; Carcinoma, Hepatocellular; Catechin; Cell Movement; Cell Proliferation; Dinoprostone; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Receptors, Prostaglandin E, EP1 Subtype; Wound Healing

2019